Natural Language Processing (NLP) is a branch of Artificial Intelligence (AI) which focuses on the application of computer science and statistical techniques to the understanding and manipulation of natural language. It is used to analyze text and speech, and provide users with insights and solutions. It involves analyzing and understanding human language and constructing machine-readable representations of the data. NLP has become a key element in the development of AI-based systems, mainly due to its ability to process and understand large volumes of data in natural language. This is possible through the use of natural language processing techniques such as tokenization, parsing, semantic analysis, and sentiment analysis. Natural language processing is used to extract meaningful insights from textual data which allows for faster and more accurate decisions. NLP is commonly used to build intelligent systems such as chatbots, virtual assistants, and automated customer service processes. For example, a chatbot can understand and respond to customer inquiries using NLP. NLP algorithms are also used in machine translation, text-to-speech, and text summarization. NLP is an important tool in many industries such as healthcare, legal, and finance. In healthcare, NLP can be used to provide medical information, detect diseases, and read medical records. In the legal profession, NLP can be used to provide legal advice, analyze documents, and identify key information. In finance, NLP can be used to read financial news, identify trends, and provide accurate summaries. NLP is rapidly growing and will continue to play a major role in the development of AI-based systems. NLP will allow us to reason more accurately and interpret contextual clues in natural language in order to provide more accurate, faster, and more intuitive solutions to various problems.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States